Gordon K Lam MD

Crystal Related, Rheumatoid Arthritis & Related, Spondyloarthropathy

Physician

801 E Morehead StSte 100Charlotte, NC 28202
Phone+1 704-342-0252
Fax+1 980-533-7801

Dr. Lam is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lam's full profile Already have an account?

Summary

Dr. Gordon Lam is a rheumatologist based in Concord, NC, with subspecialties in crystal-related diseases, rheumatoid arthritis, and spondyloarthropathy. He completed his rheumatology fellowship at Johns Hopkins University and his residency in internal medicine at Duke University Hospital, where he also attended medical school. Dr. Lam has extensive experience in managing arthritis and has contributed greatly to his field with several publications in repuTable medical journals, most of which have been highly cited. He has also been part of clinical trials, including a pilot study on predicting methotrexate responses. Dr. Lam is recognized by the National Committee for Quality Assurance under the Physician Practice Connections Recognition Program and is a fellow of the American College of Rheumatology.

Education & Training

Johns Hopkins UniversityFellowship, Rheumatology, 2004 - 2007
Duke University HospitalResidency, Internal Medicine, 2001 - 2004
Duke University School of MedicineClass of 2001
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1995 - 1997
Princeton UniversityA.B., Molecular Biology, Sigma Xi, 1991 - 1995

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NC State Medical License 2001 - 2027
MD State Medical License 2005 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification P2 Sentinel, Cerner Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2014, 2016-2017

Clinical Trials

Prediction of Methotrexate Response - A Pilot Study Start of enrollment: 2011 Dec 01
Completed

Publications & Presentations

PubMed

Treatment Sequencing and Line of Therapy for Biologics and JAK Inhibitors in Patients With Rheumatoid Arthritis: Implications for Design and Uptake of New Drugs and Pr...
Jeffrey R Curtis, Shanette Daigle, Emily E Holladay, Yujie Su, Michael George
Arthritis Care & Research. 2026-02-16
First-line tumor necrosis factor inhibitor versus abatacept treatment choice in real-world patients with anticitrullinated protein antibody- and rheumatoid factor-posi...
Gordon Lam, Hanke Zheng, Andrew Klink, Vardhaman Patel, Emily Bland
Journal of Comparative Effectiveness Research. 2026-02-01
Plain language summary: gout remission with pegloticase.
Yael Klionsky, Karina D Torralba, Katie Obermeyer, Lissa Padnick-Silver, Gordon Lam
Therapeutic Advances in Musculoskeletal Disease. 2026-01-01

Press Mentions

Aqtual Presents New Data on Development of RA Therapy Selection Test at ACR Convergence 2024November 18th, 2024
Most Rheumatologists Say COVID-19 Pandemic Exposed Mental Health as 'Key Unmet Need'November 3rd, 2021
Understanding Cytokine Pathways to Revolutionise PsA ManagementMay 28th, 2024